Remedy Pharmaceuticals, the developer of CIRARA (intravenous glyburide) for the treatment of Large Hemispheric Infarction ...

The New York Yankees are running out of options for the infield. However, this All-Star third baseman could be the answer for ...

A Houston Astros pitcher is reportedly drawing trade interest this offseason. Per the New York Post's Jon Heyman, the Chicago ...

New Yorkers rang in the Lunar New Year at Chinatown's annual firecracker ceremony on Wednesday (January 29). Spectators ...

New York City's council member Shaun Abreu sponsored a bill that would allow New Yorkers to take paid time off to care for ...

Orphism in Paris, 1910–1930,” at the Guggenheim Museum, New York.

XRP has been a big name in the crypto world, but a new competitor, Remittix, is making waves. With its pre-release nearing $10 million, Remittix is gaining attention for its real-world solutions and ...

The Orioles' and Rays' offseasons leave something to be desired, but it's reasonable to expect a strong 2025 from this group.

Analyst Jason Gerberry from Bank of America Securities reiterated a Buy rating on Royalty Pharma (RPRX – Research Report) and increased the ...

Injuries to big name players crushed the hopes and dreams of many MLB franchises in 2024. Many notable players who sat out in 2024 are expected back for 2025. Here are 10 that fans may have forgotten ...

But he struggled badly in last year's playoffs versus the rival New York Mets, going 1-2 while allowing six runs in 1 1/3 innings over three outings in their Division Series. Hoffman gets a $5 ...